OTCM
JAPAY
Market cap78bUSD
Sep 17, Last price
22.13USD
1D
2.03%
1Q
17.28%
Jan 2017
35.48%
Name
Japan Tobacco Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Japan Tobacco Inc., a tobacco company, engages in the manufacture and sale of tobacco products in Japan and internationally. It operates through two segments: Tobacco Business and Processed Food Business. It offers tobacco products, such as cigarettes, fine cut tobacco products, cigars, pipes, and hookah products. The company provides reduced-risk products, including heated tobacco, infused tobacco, e-vapor, traditional oral, and modern oral. Further, the company provides frozen and room-temperature products comprising frozen udon noodles, packed rice, and frozen okonomiyaki; and seasonings, including yeast extracts, assembled, kelp and seaweed, and oyster sauces. It offers its products under the Winston, Camel, Möbius, and LD brands. Japan Tobacco Inc. was founded in 1898 and is headquartered in Tokyo, Japan.
Related entities
Subsidiaries (7)
AUSTRIA TABAK GMBH
J.T. INTERNATIONAL (ROMANIA) SRL
JT INTERNATIONAL HOLDING B.V.
JT INTERNATIONAL MANUFACTURING SA
JT INTERNATIONAL GERMANY GMBH
JT INTERNATIONAL SA
JTI (UK) MANAGEMENT LTD
Key people
Toru Oguchi
Executive Officer, Director of China Business in Main Tobacco Business Unit
Kenji Ogura
Executive Officer · since 2017
Shigenori Ohkawa
Executive Officer, Director of Medicine General Research Institute in Medicine Business Unit · since 2014
Takehisa Shibayama
Executive Officer · since 2016
Headquarters & legal address
虎ノ門四丁目1番1号
東京都 港区 105-6927
JP
東京都 港区 105-6927
JP
Address
1-1, Toranomon 4-chome
Minato-ku Tokyo 105-6927
JP
Minato-ku Tokyo 105-6927
JP
Other language
Japan Tobacco Inc.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||